Analysis of multidrug resistant cell lines has led to the identification of the P-glycoprotein multigene family. Two of the three classes of mammalian P-glycoproteins have the ability to confer cellular resistance to a broad range of structurally and functionally diverse cytotoxic agents. P-glycoproteins are integral membrane glycoproteins comprised of two similar halves, each consisting of six membrane spanning domains followed by a cytoplasmic domain which includes a nucleotide binding fold. The P-glycoprotein is a member of a large superfamily of transport proteins which utilize ATP to translocate a wide range of substrates across biological membranes. This superfamily includes transport complexes comprised of multicomponent systems, half P-glycoproteins and P-glycoprotein-like homologs which appear to require 12 c~-helical transmembrane domains and two nucleotide binding folds for substrate transport. P-glycoprotein homologs have been isolated and characterized from a wide range of species. Amino acid sequences, the similarities between the halves and intron/exon boundaries have been compared to understand the evolutionary origins of the P-glycoprotein.
Introduction
Resistance to chemotherapeutic agents remains the major obstacle in the successful therapy of human cancer. Many tumors are intrinsically resistant to many of the most potent cytotoxic agents used in cancer therapy. Other tumors, initially sensitive, recur and are resistant not only to the initial therapeutic agents but also to other drugs which the tumor has not previously been exposed. This resistance of human tumors to multiple chemotherapeutic agents has been difficult to study in the clinical setting. However, significant progress has been made in characterizing the phenomenon of resistance to multiple cytotoxic agents in vitro Endicott and Ling, 1989; Gottesman and Pastan, 1989; Roninson, 1991) . Cell lines have been selected for resistance to anticancer agents, many of which are antibiotics originating in microorganisms or alkaloids from plants, by slowly increasing the concentration of the cytotoxic agent in a step-wise fashion. Derivative lines, many thousand fold resistant to the selecting agent, have been generated which are cross resistant to a broad spectrum of structurally and functionally diverse cytotoxic compounds. These multidrug resistant cell lines have provided an experimental model for the analysis of cellular resistance to multiple cytotoxic agents. An understanding of the biological basis of multidrug resistance has emerged which points to a unifying mechanism responsible for cross resistance to specific cytotoxic agents. Molecular analysis of the multidrug resistant cell lines has identified a gene family whose members are capable of conferring resistance to multiple cytotoxic agents and are included in a large superfamily of transport proteins.
Multidrug resistant cell lines were initially generated using anthracylines, colchicine, vinca alkaloids, or actinomycin D (Nielsen and Skovsgaard, 1992) . The cell lines usually displayed the highest level of resistance to the selecting agent with lesser degrees of resistance to the other cytotoxic agents in these categories (Table 1) . Although the compounds appear quite diverse in their structure and mode of action, many are natural products and can usually be categorized as small lipophilic cations (Beck, 1990) . In addition, a broad range of compounds, which often share structural characteristics with these substrates, have been shown to be capable of reversing multidrug resistance (Ford and Hait, 1990) . Several initial observations provided clues for understanding the mechanism of multidrug resistance. First, multidrug resistant cell lines accumulated less of the cytotoxic agents than nonresistant lines. The decreased accumulation was associated with an energy dependent outward efflux of the compounds (Dano, 1973; Skovsgaard, 1978) . Secondly, Juliano and Ling (1976) identified a 170 kD membrane glyco- Substrates included in the multidrug resistance phenotype or known to be transported by P-glycoprotein.
protein, termed P-glycoprotein (Pgp), overexpressed in multidrug resistant cell lines. The amount of Pglycoprotein in the plasma membrane appeared to correlate with the level of drug resistance. Finally, karyotypic analysis of multidrug resistant cell lines indicated the presence of double minute chromosomes or homogeneously staining regions, abnormalities consistently associated with gene amplification (Biedler and Riehm, 1970) . These observations, consistent with overexpression of a gene product responsible for decreased accumulation of cytotoxic agents, directed the means for elucidating the mechanism of multidrug resistance.
Isolation cDNAs encoding the mammalian Pglycoprotein
Using a variety of strategies, genes overexpressed in multidrug resistant cell lines have been isolated and characterized. A series of cDNAs displaying a high level of nucleic acid similarity, each encoding a polypeptide with features of the P-glycoprotein have been identified. These cDNAs have been classified based on sequence similarity and have been designated members of the mdr or pgp multigene family (Juranka et al., 1989) (Table 2) . Specific DNA sequences amplified in multidrug resistant cell lines were first identified using the technique of DNA renaturation in agarose gels (Roninson et al., 1984) . DNA sequences amplified in two independently derived hamster multidrug resistant cell lines were identified with a total length of at least 150 kbp. A 1.1 kbp BamHI fragment amplified in both cell lines was excised from the gel and cloned. This probe indicated that the 1.1 kbp BamHI fragment was amplified in both cell lines and that the level of drug resistance correlated with the level of amplification. The fragment did not, however, hybridize to a mRNA species. Using tile 1.1 kbp BamHI fragment, a contiguous 140 kbp domain amplified in the two hamster multidrug resistant cell lines was isolated (Gros et al., 1986c) . Probes spanning the amplified domain indicated that a mRNA species of approximately 5 kbp was overexpressed in the multidrug resistant cell lines. The hamster probes were used to isolated two distinct cDNAs from a nondrug resistant, mouse pre-B cell library (Gros et al., 1986a) . One of the murine cDNAs, mdrl, was capable of conferring the complete multidrug resistant phenotype when transfected into drug sensitive cell lines (Gros et aI., 1986a; Croop et al., 1987) . The second cDNA, mdr2, although highly homologous to the first, did not convey drug resistance . A third murine cDNA, mdr3, also capable of conveying multidrug resistance, was subsequently isolated from the original pre-B cell library using probes from the previously cloned cDNAs (Devault and Gros, 1990) . Two distinct human genomic clones were isolated by cross hybridization with probes from the amplified hamster domain . One of these clones, human MDR1, identified amplified DNA sequences and a 4.5 kbp mRNA species overexpressed in multidrug resistant cell lines. MDR1 was subsequently used to screen a cDNA library derived from a multidrug resistant cell line to isolate a series of overlapping human cDNA clones which encoded sequences capable of conveying multidrug resistance (Chen et al., 1986; Ueda et al., 1987) . Similarly, using an independently derived hamster mdr probe ( , a novel set of cDNAs with high homology to human mdrl were isolated from a human liver cDNA library and designated mdr3 (Van der Bliek et al., 1987 . As with mouse mdr2, transfection studies indicated that human mdr3, was not capable of conveying multidrug resistance.
Using the C219 monoclonal antibody directed against the P-glycoprotein , a 600 basepair clone, )~CHP1, was isolated from an expression library generated from a multidrug resistant hamster cell line (Riordan et aI., 1985) . Molecular analysis of multidrug resistant cell lines with XCHP1 indicated that the gene encoding the P-glycoprotein was amplified and overexpressed a mRNA of approximately 4.7 kbp. Subsequently, three members of the hamster pgp multigene family have been isolated using clones derived from s (Endicott et al., 1991) . Analysis of RNA transcripts overexpressed in multidrug resistant cell lines similarly identified cDNAs encoding P-glycoprotein. Differential screening of cDNA libraries from drug sensitive and drug resistant cell lines identified a series of 5 genes overexpressed in the multidrug resistant cell lines . All five genes where present on a single amplicon. Only the cDNA which cross hybridized with )~CHP1, however, was consistently overexpressed in a variety of multidrug resistant cell lines (De Bruijn et al., 1986) . Similarly, using Cot fractionated genomic DNA to generate a probe from amplified sequences, cDNAs encoding the P-glycoprotein were identified in a library generated from a multidrug resistant cell line (Scotto et al., 1986) .
Cross hybridization (Gros et al., 1986c; and sequence comparisons indicate that the cDNAs isolated from the human, routine and hamster libraries are members of a multigene family which encodes the P-glycoprotein. Comparisons of intron sequences (Ng et al., 1989) , untranslated sequences (Endicott et aI., 1987; Hsu et al., 1989) and coding regions (Hsu et al., 1989; Endicott et al., 1991) have identified three classes of mammalian P-glycoproteins as indicated in Table 2 . The mammalian P-glycoprotein multigene families are clustered in tandem on a single chromosome, chromosome 7 in humans (Chin et al., 1989; Raymond et al., 1990; Lincke et al., 1991) . Classes I and II are capable of conveying multidrug resistance, while class III cannot. Systematic searches have never identified a human class II, suggesting that classes I and II represent a gene duplication occurring after the separation of murine and human evolution (Chin et al., 1989; Ng et aI., 1989) .
The predicted structure of the P-glycoprotein
The isolation of cDNAs encoding the P-glycoprotein enabled analysis of the structure of the polypeptide. The nucleic acid sequences of the cDNAs which encode the mammalian P-glycoproteins predict an integral membrane gtycoprotein with remarkably similar structures (Fig. 1) . The length of the mammalian P-glycoproteins vary from 1276 to 1281 amino acids predicting a molecular weight of approximately 140 kD. This is consistent with purified or labelled P-glycoprotein which migrates at a molecular weight of 130--180 kD in polyacrylamide gels. Although P-glycoprotein mobility in polyacrylamide gels is sensitive to the conditions employed (Greenberger et al., 1988b) , approximately 10--15 kD of the observed molecular weight is accounted for by N-linked glycosylation (Greenberger et al., 1988a) . Indeed, the predicted amino acid structure of the P-glycoprotein indicates 7--10 potential N-linked glycosylation sites [N-X-S/T].
Examination of the amino acid sequence identifies a number of significant structural features (Figs. 1 and 2). Independent hydrophobicity analyses using the methods of Kyte-Doolitte (Gros et al., 1986b) and Eisenberg (Chen et al., 1986) predict a polypeptide which traverses the plasma membrane 12 times. A short, highly charged, cytoplasmic domain precedes three membrane loops which are followed by a large cytoplasmic domain. A cluster of the potential N-linked glycosylation sites are consistently located in the first external loop in virtually all P-glycoproteins. The large cytoplasmic domain includes the paired consensus sequences G- Fig. 2 . Consensus sequence for mammalian P-glycoproteins. Mammalian P-glycoproteins listed in Table 3 were aligned using the UWGCG Pileup program (gap weight of 3.0 and a gap length weight of 0.1) and the identical amino acids listed using the single letter code. The proximal and distal halves were aligned using the Gap program (gap weight 5 and gap length weight 0.3). Dots represent nonidentical residues or gap. Transmembrane domains identified under the single lines and the nucleotide binding domains under the double lines (Endicott et al., 1991) . Shaded amino acids represent identity consensus of all P-glycoproteins described in Table III except pfmdrl, STE6, mdl, ItpgpA, mrp and CFTR. Numbering includes gaps. binding fold in a wide range of ATPases (Walker et al., 1982) . The cytoplasmic domain is followed by three additional membrane loops and another large cytoplasmic domain with the consensus sequence for a second nucleotide binding fold. Experimental evidence indicates that the P-glycoprotein binds and hydrolyzes ATP (Ambudkar et al., 1992; Sarkadi et al., 1992) which is required for drug transport (Horio et al., 1988) . In addition, epitope mapping of the monoclonal antibody C219 confirms the cytoplasmic localization of the hydrophilic domain . This model of the P-glycoprotein suggests that it is comprised of two halves, each with a similar structure. A comparison of the amino acid sequence of the carboxy and amino halves indicates approximately 40% identical and an additional 25% conserved amino acid homology which has suggested duplication of an ancestral gene (Fig. 3) . The highest similarity between the moieties surrounds the nucleotide binding folds in the large cytoplasmic domains with almost 60% amino acid identity with an additional 20% conserved substitutions. When the two halves of the P-glycoprotein are aligned, a short segment termed the "linker" region ( Van der Bliek et al., 1987) which does not readily align with the corresponding region in the proximal half of the polypeptide appears to bridge the amino and carboxy halves. The linker regions of the class I and class II P-glycoproteins, which are capable of conveying drug resistance, each contain consensus sequences for cAMP-and cGMP-dependent protein kinase phosphorylation sites, while the class III members do not (Hsu et al., 1989) . Analysis of P-glycoprotein in vesicles from multidrug resistant cell lines indicates that phosphorylation occurs exclusively on serine residues including at least three in the "linker" region (Chambers et al., 1993) . Similar sites are found in the first cytoplasmic domain of the two human P-glycoproteins but not in the murine or hamster homologs. In addition, a large number of potential casein kinase II, tyrosine kinase and Fig. 3 . Amino acid identity between the amino and carboxy half of the P-glycoprotein homologs. The two halves of the P-glycoproteins aligned using the UWGCG Gap program. protein kinase C phosphorylation sites span the length of all the members of the P-glycoprotein family.
Recently, the topography of the P-glycoprotein predicted by the hydrophobicity analysis has been questioned. An extracellular glycosylation site has been identified between predicted transmembrane domains 8 and 9 utilizing an in vitro translation assay (Zhang and Ling, 1991) . Similarly, this region would be placed on the extracellular side of the plasma membrane based upon its localization within the lumen of the endoplasmic reticulum (Skatch et al., 1993) . These observations suggest that this domain is extracellular, not on the cytoplasmic side as indicated by the hydropathy analysis. Models placing predicted transmembrane domain 8 on the outside of the cell with predicted transmembrane 9 or 10 traversing the membrane back to the cytoplasmic side have been proposed to account for these observations. Only four loops would traverse the membrane in the carboxy half of the P-glycoprotein, i.e., predicted domains 7, 9 or 10, 11 and 12. Likewise, analysis of the amino half of the P-glycoprotein with the in vitro translation assay indicates that predicted transmembrane domain 3 is intracellular and predicted transmembrane domain 5 extracellular (Zhang et al., 1993) . This would suggest that the amino half also has only four transmembrane loops with predicted transmembrane domains 1, 2, 4 and 6 traversing the plasma membrane. Based on the lengths of the intracellular and extracellular domains, this model indicates that the two halves of the P-glycoprotein are not tandem duplications but rather topographical mirror images. Interestingly, the experimental data for both the amino and carboxy halves indicate that only a portion of the polypeptides have moieties comprised of four transmembrane loops. The remainder have a structure consistent with the model predicted by the hydrophobicity analysis. These data suggest that the P-glycoprotein may have two or more conformational structures. Whether these configurations are dynamically interchangeable in the plasma membrane, required for drug transport, or are associated with discrete functions remains to be clarified.
A growing body of evidence suggests that the Pglycoprotein may function as a dimer. Freeze fracture analysis of multidrug resistant cell lines demonstrates an increase in the density of intramembrane particles with a diameter predicting a molecular mass of 340 kD (Sehested et al., 1989) . The particles cluster in the presence of verapamil, although not doxorubicin, suggesting they may represent localization of the P-glycoprotein. These results are complemented by radiation inactivation analysis of membrane preparations from multidrug resistance cell lines indicating that the P-glycoprotein has a molecular mass of 250 kD, about twice the size of the unglycosylated polypeptide (Boscoboinik et al., 1990) . Finally, immunoprecipitation of P-glycoprotein from multidrug resistant cells incubated with a cross-linking agent identifies a minor band at 340 kD in addition to the major 180 kD species (Naito and Tsuruo, 1992) . The 340 kD band is photolabelled with 3H-Azidopine, but only the 180 kD species is detected when the cells are treated with a reversible cross-linking reagent. These observations provide indirect evidence for a quaternary structure of the P-glycoprotein as a dimer in the membrane.
Homology amongst the mammalian P-glycoproteins
The mammalian P-glycoproteins display a high level of primary structure homology with 69--94% amino acid identity and up to an additional 10% conserved substitutions (Figs. 4A and 5). The highest homologies exist within each of the Pglycoprotein classes (87--94% identical, Fig. 5 ). The family members which convey multidrug resistance are more similar to each other than they are to the homologs which do not convey resistance both within and across each species. A lower than Table 3 were aligned using the UWGCG Pileup program and identical residues determined using the Distances program. Abbreviations as in Fig. 3 . . Graphical analysis of amino acid identities among all Pglycoproteins. Percent identical residues of any two P-glycoproteins can be determined by comparing level of gray at the x and y axis intercept with the scale at the right. Scale indicates percent amino acid identity as a shade of gray from 0 to 1.0. Percent identical residues between any two P-glycoproteins determined as described in Fig. 4 . Abbreviations as in Fig. 3 . expected silent nucleotide replacement has suggested that hamster class I and II may not have evolved independently from each other and that gene conversion may have occurred to account for high levels of nucleic acid homology within each of the species (Van der Bliek et at., 1988b; Hsu et al., 1989; Endicott et al., 1991) .
A graphical representation of the amino acid similarity among the P-glycoproteins can be displayed using the Plotsimilarity analysis (Devereux et al., 1984) . In this analysis, amino acids are compared at each position in a series of aligned polypeptides. A score is given for the amount of similarity within a window of 10 residues and plotted along the length of the polypeptide. A value of 1.5 is given for identical amino acids, while lesser values are given for homologies based on the Dayhoff amino acid substitution table. Plotsimilarity analysis of all mammalian P-glycoproteins (Fig. 6A) indicates that the highest levels of homology are located in the cytoplasmic domains (amino acids 400--600 and 1100--1300). Several notable regions account for the majority of the difference between the family members. The region with the largest amount of amino acid divergence is located in the first external domain, in the region of amino acids 80--120. A similar, but not quite as extensive, amount of divergence is present in the corresponding region in the carboxy half of the polypeptide, external domain four encompassed by amino acids 720--760. Finally, the cytoplasmic domain at the amino terminus and the corresponding region at the beginning of the carboxy half of the polypeptide (amino acids 640--700) are quite divergent among the P-glycoproteins.
Plotsimilarity analyses of P-glycoprotein class I (Fig. 6B ), class II ( Fig. 6C ) and class III (Fig. 6D) indicates a similar pattern of amino acid homology along the polypeptide. As expected, based on higher homologies within each class of P-glycoprotein, amino acid homology along the entire length of the polypeptide is higher with values closer to 1.5. In addition, the regions of highest homology and divergence are located in similar regions found in the comparison of all the mammalian homologs. However, several notable features are observed. First, the degree of divergence in the first external domain present in class I and class II P-glycoproteins is almost as high as found across all of the classes (Fig. 6A) . In this region, around amino acids 80--120, the general increased homology within the class does not appear to apply. This divergence is found between the murine and hamster as well as the human homologs (data not shown). Second, there is very little divergence in the amino acid sequence of the first or fourth external domain in the class III P-glycoproteins (Fig. 6D , amino acid regions 80--120 and 720-760). This high level of amino acid conservation in the first external domain of the human, mouse and hamster class III P-glycoproteins is quite remarkable since this is the region of the polypeptide which displays the highest level of divergence amongst the class I and II P-glycoproteins. This is also the same region which displays the most divergence among the different classes within each species (data not shown). Specific functional requirements appear to have resulted in differential evolution of this domain. Finally, the high level of homology along the entire length of the P-glyco- Table 3 aligned with UWGCG Pileup program and the running average of the amino acid similarities plotted along the length of the polypeptides as described in text. Dashed line represents average similarity. Position in amino acids.
proteins, exemplified by scores approaching 1.5, is indicative that the analogous amino and carboxy halves of different P-glycoproteins display considerably higher similarity than the two halves of any individual P-glycoprotein, both within and across the different classes (compare Figs. 4A and 5 with Fig. 3 ).
P-glycoprotein expression
The identification of molecular and immunological probes for the different classes of P-glycoprotein provided a means to precisely examine their expression in multidrug resistant cell lines and normal tissues. Most multidrug resistant cell lines generated by stepwise selection overexpress P-glycoprotein at levels proportional to the amount of drug resistance. Characterization of human multidrug resistant cell lines indicates that at relatively low levels of resistance, mdrI transcripts are overexpressed prior to DNA amplification Lemontt et al., 1988) . As resistance increases with selection to higher drug concentrations, an increased number of mdrl gene copies are present. RNA overexpression, however, remains increased out of proportion to the amount of gene amplification, often exceeding a 10-fold excess in transcripts (Shen et al., i986; Van der Bliek et al., 1988a) . Although the mdr3 gene is often amplified at levels similar to mdrl, RNA expression is usually not detected. Expression of both class I and II P-glycoproteins correlates with multidrug resistance in murine cell lines (Hsu et al., 1989; Raymond et al., 1990) . At relatively low levels of resistance, murine lines which overexpress class I P-glycoprotein have increased mdr transcripts prior to gene amplification. Highly resistant lines express more class I RNA than would be expected from the amount of DNA amplification, similar to the human cell lines. In multidrug resistant cell lines which overexpress class II P-glycoprotein, however, both RNA expression and gene amplification are proportional and roughly parallel the level of resistance. The genes for both class I and II P-glycoproteins are consis-tently amplified in highly resistant cell lines, however, differential levels of transcriptional activation indicate that they are independently regulated. High levels of either or both class I and II P-glycoproteins may be present and the relative contribution may change with the level of selective pressure. The gene encoding class III P-glycoprorein is often amplified to similar levels, however, expression is quite variable and does not correlate with resistance.
Analysis of RNA (Fojo et al., 1987; Baas and Borst, 1988; Chin et al., 1989; Croop et al., 1989; Trezise et al., 1992) and protein expression (Thiebaut et al., 1987; Sugawara et al., 1988; Thiebaut et al., 1989; Bradley et al., 1990; Cordon et al., 1990; Georges et al., 1990) indicates that the Pglycoprotein genes are differentially expressed in normal mammalian tissues. Either or both classes I and II in mice and hamsters are expressed in tissues where human mdr! is expressed. P-glycoprotein is consistently expressed at high levels at a variety of secretory surfaces including the bile canaliculi (Buschman et al., 1992) , the proximal tubules of the kidney, and intestinal and colonic epithelium. P-glycoprotein is also detected at the epithelial surfaces of the pancreas, bronchial mucosa, ovarian follicles and prostate. A dramatic increase in P-glycoprotein expression occurs in the murine uterus during gestation (Arceci et al., 1988; Arceci et al., 1990) . The low levels normally present in the epithelium lining the uterine cavity and secretory glands gradually increase under the combined control of estrogen and progesterone to the highest levels found in mouse tissues. Expression of the cystic fibrosis gene (see below) appears to complement that of mdr in a variety of secretory epithelial tissues, including the uterus. The high levels of expression of the cystic fibrosis gene found in the nonpregnant uterine epithelium decrease to very low levels during pregnancy (Trezise et al., 1992) .
P-glycoprotein expression is high in other specialized tissues in addition to those with epithelial secretory surfaces. Very high levels of expression are found in the adrenal gland, primarily in the cortical regions. Observations in hamsters indicate that the high level of adrenal expression is limited to males, suggesting P-glycoprotein may be involved in the transport of sex specific hormones . P-glycoprotein is also expressed in capillary endothelia in a variety of tissues. Expression is most notable in capillaries found in the central nervous system, testes, uterus and the papillary dermis of the skin, which has prompted speculation that P-glycoprotein may play a role in establishing the blood brain barrier (Cordon et al., 1989) . P-glycoprotein expression has also been observed in hematopoietic stem cells (Chaudhary and Roninson, 1991) and mature lymphoid cells (Chaudhary et al., 1992; Drach et al., 1992) . Finally, class III P-glycoprotein is specifically expressed in human liver, spleen and kidney as well as in murine adrenal and hearttissues where classes I and/or II are also expressed. The exact cellular localization of the different classes remains to be addressed.
Unfortunately, analysis of P-glycoprotein expression in normal tissues has not provided significant insight on its normal physiological role. In addition, differences in molecular probes, immunological reagents and fixation protocols have produced a number of discrepancies between laboratories. Differences in expression between individual samples have also been noted. Finally, the sensitivity of the various techniques and reagents remain to be clarified and a general agreement on the best methodology for P-glycoprotein detection is lacking (Herzog et al., 1992) . Although quantitative analysis of RNA expression by the polymerase chain reaction appears to be the most sensitive method, the inclusion of connective tissue in the samples and potential lack of correlation between RNA and protein expression in cells not selected for drug resistance (Hill et al., 1990; Wu et al., 1992) may confound the analysis. Characterization of protein expression using immunological methods is reliable for detecting protein, but sensitivity at low levels of expression has not been clarified (Toth et al., 1992) . Differences in protein function due to differential glycosylation and phosphorylation are only now beginning to be addressed. It is clear that issues remain in characterizing P-glycoprotein expression and function in both normal and malignant tissues.
P-glycoprotein homologs
P-glycoprotein homologs have been isolated from a wide range of species. Analysis of cDNA and genomic clones indicate a high level of amino acid similarity and structural conservation, based on hydrophobicity analyses, present across large evolutionary distances. High levels of similarity even remain in the nucleic acid sequence in many of the distant homologs. Isolation of multiple Pglycoproteins and cross hybridization of genomic DNA to molecular probes indicate the presence of a multigene family in most organisms (Juranka et al., 1989) . Although specific functions have not yet been identified for many of the P-glycoprotein homologs, the variability in the number of family members and the divergence in the primary sequence suggest that this transport protein has readily adapted to a range of functional capacities. Recent observations on the ability of the human Pglycoprotein to function as an ATP (Abraham et al., 1993 ) and a volume regulated chloride channel implies multiple mechanistic properties associated with the polypeptide and have challenged the traditional distinctions between transporters and channels (Jan and Jan, 1992). Figures 3, 5 and 7 show the homologies between the amino acid sequences of the P-glycoprotein homologs and should be referred to for the comparisons described in the text.
Saccharomyces cerevisiae
The yeast Saccharomyces cerevisiae STE6 gene encodes a P-glycoprotein homolog (Kuchler et al., 1989; McGrath and Varshavsky, 1989) . STE6 is one of several nonlethal "sterile" mutations in MATa cells which inhibit haploid S. cerevisiae mating and the formation of diploid cells. MATa cells secrete a factor, a 12 amino acid, peptide pheromone which induces conjugation. The a factor lacks a hydrophobic N-terminal signal sequence and sites for N-linked glycosylation suggesting that it is not exported using traditional secretory pathways. However, a factor does undergo post-translational farnesylation and methylation which render it lipophilic. Yeast carrying the STE6 mutation produce a factor but are unable to secrete the peptide to the extracellular space while overexpression of STE6 results in a striking increase in the amount of a factor released from the cells (Kuchler et al., 1989) . Analysis of the predicted structure of the STE6 protein product reveals a polypeptide with 1290 amino acids comprised of 12 membrane spanning domains and two cytoplasmic domains containing nucleotide binding folds. The hydrophobicity profiles of STE6 and the mammalian P-glycoproteins are nearly superimposable. The two halves of the STE6 gene product have approximately 27% amino acid identity and a total of 50% amino acid similarity. There is approximately 25% amino acid identity with the mammalian P-glycoproteins along the entire polypeptide, with the highest homology, approximately 40%, in the nucleotide binding domain. The homology to P-glycoprotein has suggested that STE6 is a transport protein capable of translocating a factor to the extracellular space in a fashion distinct from classical secretory pathways. The requirement that a factor undergo hydrophobic modification implies that lipophilicity may be a general property of P-glycoprotein transport substrates and that the natural transport products of the mammalian homologs may undergo similar functional modification (McGrath and Varshavsky, 1989) . Preliminary observations suggest that yeast deficient in STE6 were more sensitive to the peptide antibiotic valinomycin, while overexpression of the gene results in resistance (Kuchler et al., 1989) . Cross hybridization of S. cerevisiae genomie DNA by STE6 probes suggests that additional P-glyeoprotein homologs remain to be identified.
In spite of significant amino acid divergence between the mammalian and yeast homologs, murine mdr3 is capable of transporting a factor in STE6 deficient S. cerevisiae (Raymond et al., 1992) . Although export is less efficient than STE6, functional homology across a large evolutionary distance appears to remain. Similar experiments with human mdrl indicate that the human homolog is not capable of a factor transport even though homology between the mammalian P-glycoproteins is much higher to each other than to STE6 (Kuchler and Thorner, 1992) . Expression of human mdrl in yeast did, however, convey resistance to valinomycin. These functional assays for the murine and human homologs expressed in S. cerevisiae should provide a useful system for rapid mutational analysis of the mammalian homologs. Such an analysis has provided new insights on the structural and functional requirements of STE6 transport of a factor. Mutations generated in either the proximal or distal nucleotide binding domains of STE6 inhibit export of a factor suggesting that each half of the polypeptide is required for specific functional activities (Berkower and Michaelis, 1991) . Similarly, expression of either half of STE6 is not sufficient for export of a factor. Co-expression of the two halves, however, does result in export of a factor. This observation suggests that the two halves can self assemble in the plasma membrane to form a functional STE6 transporter. This probably reflects the underlying structural organization and functional interactions required of the hydrophobic and nucleotide binding domains required for P-glycoprotein and related membrane transport proteins ( Fig. 8 and see below) .
Schizosaccharornyces pombe
A P-glycoprotein homolog has been isolated from a leptomycin B resistant strain of Schizosaccharomyces pombe (Nishi et al., 1992) . Leptomycin B is an antifungal antibiotic isolated from a strain of Streptomyces which induces morphological abnormalities in a variety of fungi including the fission yeast S. pombe. A Ieptomycin B resistant strain of S. pombe identified after chemical mutagenesis has been utilized to characterize the genes responsible for resistance. A genomic library from the resistant line was cloned into a multicopy expression vector and introduced into a susceptible stain. Three distinct clones were identified which were capable of conveying leptomycin B resistance. Genetic analysis of the clone which conveyed the highest level of resistance suggested that it was not a mutant gene, but rather a wild-type gene able to confer resistance when carried on a multicopy plasmid. Overexpression of this plasmid resulted in resistance to leptomycin B, cycloheximide, valinomycin and staurosporine B but not actinomycin D. Disruption of the wild-type gene indicated that it was nonessential, however, the null mutant was hypersensitive to the agents to which it conveyed resistance as well as actinomycin D. Analysis of the clone indicated that an open reading frame consisting of 1362 amino acids with similarity to the predicted amino acid sequence of the P-glycoprotein was responsible for resistance. was designated pmdl + for S. pombe mdrl-like gene.
The primary structure predicted a polypeptide with two similar halves, each containing six transmembrahe domains and a nucleotide binding domain. Pmdl § has higher amino acid identity to the mammalian P-glycoproteins (37--40%) than to the yeast homolog STE6 (24%).
Plasmodium falciparum
The rapid emergence of Plasmodium falciparum resistant to antifolate antimalarials has led to a dependence upon quinoline-containing compounds for the treatment and prophylaxis of malaria. Parasites resistant to these newer agents, however, are increasingly prevalent in most endemic areas of the world, posing a serious threat to control of the disease. Analysis of resistant P. falciparum initially suggested that the organisms displayed a phenotype similar to mammalian multidrug resistant cell lines.
Isolates found in the wild were shown to be resistant to multiple antimalarials such as chloroquine, mefloquine and quinine . In addition, P. falciparum isolates resistant to chloroquine were shown to efflux radiolabelled chloroquine 40--50 times more rapidly than susceptible strains, even though the initial uptake rates were similar (Krogstad et al., 1987) . Finally, verapamil and diltiazem, reversal agents of mammalian multidrug resistance, as well as vinblastine and doxorubicin all were shown to increase the accumulation of chloroquine in the resistant but not the susceptible isolates (Krogstad et al., 1987; Martin et al., 1987) . These observations suggested that a P-glycoprotein homolog may have been involved in the resistance phenotype of P. falciparum.
Evidence for P-glycoprotein homologs in P. falciparum was obtained by screening genomic libraries using degenerate oligonucleotide probes to sequences in the highly conserved nucleotide binding fold (Foote et al., 1989) and analysis of polymerase chain reaction products which were designed to span the nucleotide binding fold (Wilson et al., 1989) . The complete coding region of pfmdrl reveals a polypeptide of 1420 amino acids in length consisting of two homologous halves that each contain six transmembrane regions and a nucleotide binding domain (Foote et aI., 1989) . A stretch of approximately 50 additional amino acids, not present in other P-glycoproteins, is inserted between the two consensus sequences which comprise the nucleotide binding folds. The entire polypeptide displays approximately 30% amino acid identity to the mammalian homologs and each of the two homologous halves are more similar to the mammalian homologs than they are to each other.
Characterization of the role of pfmdrl in antimalarial resistance has been hampered by the lack of a genetic model in P. falciparum. The inability to transfect or amplify pfmdrl in susceptible isolates has limited the analysis of defining whether the gene plays a direct role in drug resistance. Conflicting evidence has further confounded its role in drug resistant P. falciparum. Over half of the analyzed chloroquine resistant isolates have amplified pfmdrl (Triglia et al., 1991; Wilson et al., 1993) . Pulsed field electrophoresis indicate that pfindrl is amplified as a head to tail, tandem array of repeats on chromosome five where the gene is normally located. Amplification of pfmdrl in resistant isolates correlates with overexpression of two stage specific transcripts . A 8.5-kbp transcript is expressed in both ring and trophozoite stages, while a 7.5-kbp transcript is only expressed in trophozoites. Similarly, quantitative immunoblotting indicates that the protein is not overexpressed in resistant isolates unless the gene has been amplified . However, the gene product does localize to the digestive vacuole, where chloroquine normally accumulates, suggesting that it may modulate intracellular chloroquine concentrations.
Analysis of the pfindrl gene in chloroquine resistant isolates indicated the presence of two alleles correlating with resistance (Foote et al., 1990) . Amino acid substitutions occur at locations where independent mutations affect the ability of the mammalian P-glycoprotein to transport specific cytotoxic substrates out of the cell (Choi et al., 1988; Gros et al., 1991) . Examination of the predicted amino acids at these positions correctly identified whether 34 of 36 P. falciparum isolates were resistant. Although these observations suggest that overexpression of the pfmdrl gene product would not be required for chloroquine resistance, mutations in another gene might also be required due to the low frequency of alleles found.
The original characterization of a chloroquine resistant isolate, W2, which had subsequently been placed under stepwise selection of mefloquine in vitro, W2mef, indicated that amplification and overexpression of pfmdrl was associated with mefloquine resistance but not chloroquine resistance (Wilson et al., 1989) . Evaluation of P. falciparum from patients failing standard therapies has similarly suggested a correlation between mefloquine resistance and pfmdrl amplification . Although there was no correlation between the presence of the alleles described above and chloroquine resistance, amplification of the pfmdrl gene was found in 10 of the 11 isolates. All 10 of the isolates which had amplified pfmdrl were resistant to all compounds tested. The only isolate which did not display amplification of pfmdrl, however, was sensitive to mefloquine and halofantrine.
A role for pfmdrl in conveying resistance to antimalarials in P. falciparum could not be found utilizing a genetic cross between chloroquine resistant and sensitive parasites (Wellems et al., 1990) . The cross was made between a chloroquine sensitive line, HB3, containing a single copy of pfmdrl, and a resistant line, Dd2, a derivative of W2mef, which contains four copies. Gametocytes from the two lines were produced in vitro, fed to mosquitoes which subsequently fed on a chimpanzee. Individual progeny of the cross were isolated from the blood by limiting dilution. Eight chloroquine resistant and eight sensitive isolates were identified and characterized in vitro. Each of the progeny clones displayed a sensitive or resistant phenotype identical to one of the parents. There were no phenotypes of intermediate resistance.
Neither the number of copies of Dd2 pfmdrl, or even the presence of Dd2 pfmdrl correlated with chloroquine resistance. Resistant and sensitive isolates where just as likely to receive pfrndrl from either parent. Similarly, there were no significant differences among the parent or progeny clones in the level of mefloquine resistance. Analysis of the sensitive HB3 parent, however, has indicated that it has one of the alleles associated with chloroquine resistance and in addition, may be somewhat resistant to mefloquine (Foote et al., 1990) . The analysis of this cross could be complicated if the HB3 pfmdrl gene has the ability to convey resistance. Although this cross does not appear to implicate pfmdrl, it does suggest, however, that a single genetic locus is responsible for chloroquine resistance.
Leishmania
Leishmania is an intracellular parasite responsible for a range of clinical syndromes including cutaneous, mucosal and visceral infiltration. The treatment of choice remains pentavalent antimonials. One mechanism of resistance in Leishmania selected with heavy metals, methotrexate, primaquine, or terbinafine correlates with amplification of H circles (Ellenberger and Beverley, 1989; Ouellette et aL, 1990) . H circles are extrachromosomal genetic elements comprised of a 30 kbp inverted repeat separated by unique DNA segments which encode at least 20 polyadenylated RNAs. Amplification occurs from pre-existing circles or the de novo generation of H circles from a chromosomal copy. The chromosomal copy contains only a single copy of the duplicated region indicating that the circles cannot be formed by a simple excision (Ouellette et al., 1991) . A P-glycoprotein homolog, ltpgpA, was first identified in amplified H-circles from L. tarentolae using cross hybridization to a mammalian mdrl probe (Ouellette et al., 1990) . Cross hybridization of genomic DNA with molecular probes suggests that there are at least five Pglycoprotein homologs. Sequence analysis of ItpgpA indicates a continuous open reading frame of 1548 amino acids encoding a polypeptide with two similar halves, each containing six transmembrahe domains and a nucleotide binding fold.
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Homology to mammalian P-glycoproteins extends only to the 200 amino acids surrounding the nucleotide binding domain as indicated by only 15% amino acid identity with the entire polypeptide. There does not appear to be significant homology between the two halves of ltpgpA outside of the nucleotide binding domain with only 21% amino acid identity between the halves. In addition, the amino terminus is much longer than the corresponding region in the mammalian homologs. These differences, as well as closer homology to other P-glycoprotein-like transport proteins (Figs. 5 and 7, see below) have suggested that ltpgpA may be distinct from the other P-glycoproteins (Cole et aI., 1992) .
Isolation and expression of four DNA fragments spanning the H region of L. major have implicated ImpgpA, the homolog of ltpgpA, as conveying resistance to the heavy metals arsenite, antimony and lead (Callahan and Beverley, 1991) . Introduction of the H region fragment which includes lmpgpA and further amplification by co-selection with the neomycin resistance gene confers heavy metal resistance to the parasite. There was no increase in resistance to cytotoxic agents included in the mammalian multidrug resistant phenotype such as vinblastine and puromycin. Resistance was associated with a two fold decrease in arsentite accumulation. Similarly, when clones which included ltpgpA were introduced into the parasites, a similar pattern of heavy metal resistance was obtained although the level was approximately 2--4-fold less than with the ImpgpA constructs. Similarly, a P-glycoprotein-like transport protein in yeast, HMT1, has recentIy been shown to convey resistance to heavy metals (Ortiz et al., 1992) . Analysis of an H circle in L. tarentolae amplified during selection with arsenite revealed a novel fusion of ltpgpA and a second P-glycoprotein homolog designated ItpgpB which resides just outside the chromosomal location of the H region (Ouellette et al., 1991) . The exact alignment of the sequences of the P-glycoprotein homologs suggests that the H circle was formed by intrachromosornal homologous recombination between ltpgpA and ItpgpB.
Selection of L. donovani with increasing concentrations of vinblastine have successfully gener-ated parasite lines cross resistant to vinblastine, daunorubicin and puromycin (Henderson et al., 1992) . The resistant parasites display markedly decreased uptake of radiolabelled puromycin. Drug resistance, however, was not reversed with either verapamil or quinidine even though the parasites displayed a multidrug resistant phenotype similar to mammalian multidrug resistant cells. Probes were generated to determine whether amplification of a leishmanial P-glycoprotein homolog correlated with drug resistance. Two polymerase chain reaction products designed to span a nucleotide binding fold were isolated and characterized. The product with approximately 50--55% amino acid identity to the murine nucleotide binding domain indicated that homologous genomic sequences were amplified 50-fold in the multidrug resistant parasites. Hybridization with the product which displayed 35--40% amino acid identity and a probe from ltpgpA revealed no evidence of amplification. Northern blot analysis indicated that a 12.5 kbp mRNA was overexpressed in the resistant parasites. A 5.7 kbp genomic clone from L. donovani with the complete coding sequence _of ldmdrl was isolated using the polymerase chain reaction product, transfected into Leshmania and amplified by co-selection with the neomycin resistance gene. The transfected parasites displayed the same multidrug resistant phenotype as the original resistant organisms. Similar results have been obtained by selecting L. enriettii with vinblastine (D. Wirth, personal communication). An analogous gene, lemdrl (Genbank accession L080-91), has been isolated from L. enriettii which is amplified on a 35--40 kbp extrachromosomal circle in the resistant organisms. Analysis of the predicted amino acid sequences reveal polypeptides with a hydrophobicity profile similar to the mammalian Pglycoproteins, 83% amino acid identity with each other but only 24% identity to ItpgpA. There is approximately 37% amino acid identity to the mammalian homologs indicating that Idmdrl and lemdrl, which convey multidrug resistance to hydrophobic substrates, are much closer evolutionarily to the mammalian P-glycoproteins than to ltpgpA (Figs. 4, 5 and 7) .
Drosophila
Three members of the Drosophila mdr multigene family have been isolated and characterized. The Pglycoprotein homologs have been designated relative to their chromosomal location, Mdr49 on chromosome two, Mdr65 on chromosome three (Wu et al., 1991) and Mdr50 also on chromosome two, but far from Mdr49 (M. Dean, personal communication). Each of the Drosophila genes are localized at different chromosomal locations, in contrast to the mammalian multigene family which is clustered on a single chromosome. Mdr49 and Mdr65 were isolated from a Drosophila head cDNA library using a murine mdrl cDNA probe which included the sequences for the nucleotide binding fold. Mdr50 was isolated using a probe generated from a polymerase chain product encompassing an nucleotide binding domain. The predicted amino acid sequence for all three P-glycoprotein homologs indicate that the polypeptides have two homologous halves, each with six transmembrane domains and a nucleotide binding fold. The Drosophila homologs display approximately 40--45% amino acid identity to the mammalian homologs. However, the nucleic acid and amino acid sequences of the Drosophila P-glycoproteins are as divergent from each other as they are from the mammalian homologs, in contrast to the mammalian mdr families which display a high level of intraspecies similarity (compare Figs. 4A and B) . Preliminary observations indicate that Mdr49 and Mdr65 are differentially expressed at the secretory surfaces of tissues analogous to mammalian structures where P-glycoprotein is expressed (R. Arceci and J. Croop, unpublished 
data).
Mdr49 is located in a chromosomal region which has been the subject of previous genetic analysis (Wu et al., 1991) . The precise genetic location of Mdr49 relative to the deficiencies with known chromosomal breakpoints in the region was determined using probes spanning the cDNA. Three deficiencies were identified which had chromosomal breakpoints within the Mdr49 gene. vg 135 had a breakpoint in the proximal coding region, vg c near the center of the gene and vg ~38 probably just distal to the coding region. In addition, the b8 line deleted the entire gene. Each of the deficiencies is a large chromosomal deletion which is homozygous lethal. However, the identification of deleted and disrupted Mdr49 genes in the previously generated deficiencies allowed genetic crosses resulting in flies lacking a wild-type Mdr49 gene. Utilizing the balancer chromosome, CyO, which gives flies curly wings, vg13S/CyO and vgC/CyO flies were mated with bS/CyO flies. The flies with straight wings would be the vg135/b8 and vgC/b8 progeny with Mdr49 deleted on the b8 chromosome and disrupted on the other. Molecular analysis indicated loss of chromosomal material and truncated mRNA species consistent with the predicted genetic localization.
Functional analysis of the mutant Mdr49 fly lines indicated that they were fertile and viable under laboratory conditions. The lack of a lethal phenotype was consistent with previous saturation mutagenesis in the region which had not identified any vital genes in the location of Mdr49. The effect of losing the Mdr49 gene in flies stressed with a cytotoxic agent was ascertained by determining the survival of flies developing on colchicine. Fertilized eggs were placed on media containing increasing concentrations of colchicine and the number of adult flies emerging determined for 19 randomly chosen control lines and the flies bearing a disrupted Mdr49. The vgC/b8 flies were approximately two fold more sensitive to colchicine than the controls and could easily be distinguished from survival of any of the other lines at 10 jaM colchicine. Neither the vg13S/b8 or the heterozygous vg 135, and vg c and b8 lines showed an increased sensitivity to colchicine. Thus the loss of the wildtype Mdr49 in and of itself did not cause the heightened colchicine sensitivity during development. It is possible, however, that the remaining portion of the disrupted Mdr49 gene gives rise to a truncated or fusion protein or RNA species which is deleterious to development on colchicine. The vg c RNA transcript from the flies with increased sensitivity includes almost half of the Mdr49 coding sequence while the vg 135 transcript is very short and unlikely to provide deleterious information. Isolation and expression of the Mdr49 gene from the vg c chromosome should help elucidate 17 whether these possibilities are responsible for the increased sensitivity to colchicine in the flies with a disrupted Mdr49.
Entameoba histolytica
Entameoba histolytica is an enteric protozoan responsible for amoebic dysentery in man. Although drug resistance has not been a major therapeutic problem, case reports of failed drug treatment have been described. E. histolytica mutated with ethylmethane-sulphonate and selected in emetine have resulted in a resistant clone with a stable phenotype. Probes generated from polymerase chain reaction products predicted to span the nucleotide binding fold identified four distinct DNA fragments containing P-glycoprotein-like sequences (Samuelson et al., 1990) . The probes identified 4.5-5 kbp mRNAs overexpressed in the emetine resistant line. When the resistant line was selected with increasing concentrations of emetine, higher levels of mRNA expression were observed. The sequences for two P-glycoprotein homologs, Enhpgpl and Enhpgp2, have been characterized in detail (Descoteaux et al., 1992) . The two homologs are 1302 and 1310 amino acids in length displaying a higher level of amino acid identity to each other, 67%, than to other P-glycoprotein homologs. This is in contrast to Drosophila, Leishmania and C. elegans where similarities between P-glycoproteins within the same organism are no greater than the similarities to homologs in other species. Each of the E. histolytica homologs display approximately 38--40% amino acid identity with the mammalian P-glycoproteins. The predicted structure is very similar to the mammalian P-glycoprotein except that the amino terminus is not as hydrophilic. Two pseudogenes of the P-glycoprotein were also identified.
Arabidopsis thaliana
A P-glycoprotein homolog has been identified in the plant A. thaIiana (Dudler and Hertig, 1992) , Degenerate oligonucleotides corresponding to highly conserved amino acid sequences in the nucleotide binding fold were used to screen a genomic library. Two distinct classes of genomic sequences were obtained, and one atpgpl, further characterized. The predicted polypeptide was 1286 amino acids in length consisting of two similar halves, each comprised six transmembrane domains and a cytoplasmic domain with the consensus sequences for a nucleotide binding domain. The two halves displayed 37% amino acid identity with each other and 36--39% amino acid identity with the mammalian P-glycoproteins. Northern blot analysis indicated that atpgpl was expressed in all parts of the plant examined, including the leaves, roots, flower buds and open flowers. Highest levels of expression of the 4.5 kbp transcript were found in the peduncles.
Caenorhabditis elegans
Four homologs have been identified in the C. elegans pgp multigene family (Lincke et al., 1992) . Three sets of genomic clones, which each mapped to a different chromosome, were isolated using a human mdrl probe. Further analysis of the clones indicated that four P-glycoprotein gene homologs were present in the three genetic loci. cDNAs for two of the homologs, Celpgpa and Celpgpc, have been characterized in detail. They encode polypeptides 1321 and 1254 amino acids in length. Each is comprised of two homologous halves containing six transmembrane domains and a cytoplasmic region with a nucleotide binding fold. The hydrophobicity plots of both homologs are virtually superimposable on that of human mdrl. The two homologs, however, have only 40% amino acid identity with each other and 38--40% amino acid identity with the mammalian P-glycoproteins. The two genes have 14 and 13 exons, respectively. Although the C. elegans homologs share only one intron/exon junction, there are four and five intron positions, respectively, conserved with the mammalian mdr genes. Partially processed RNA transcripts for one of the P-glycoprotein homologs increased with growth of the nematodes at heat shock temperatures over an 8-h period. There were no increases with arsenite or actinomycin D, however, prolonged exposure to emetine appears to have resulted in increased expression. Transformation of nematodes with expression constructs which fuse the promotor regions of the two gpg genes with lacZ coding region indicate that expression of both genes is restricted to the intestinal cells (Lincke et al., 1993) .
Other P-glycoprotein homologs
A P-glycoprotein homolog has been isolated from Escherichia coli and designated Mdl (Genbank accession L08627). It has a similar structure to the P-glycoproteins except that the amino end appears truncated with only five transmembrane domains.
There is approximately 20--25% amino acid identity with the other P-glycoprotein homologs. Partial sequences for two P-glycoproteins have been isolated from winter flounder using hamster pgp probes and have highlighted the difficulty in relating specific homologs to the mammalian classes (Chan et al., 1992) . Finally, a P-glycoprotein homolog, Smdr2, has been isolated from the parasite Schistosoma mansoni using a polymerase chain reaction product generated to span a nucleotide binding domain (I. Bosch and C. Schoemaker, personal communication).
Evolutionary homologies
A comparison of the amino acid sequence of the Pglycoprotein to the protein sequences in the genetic databases indicates homology to a rapidly expanding group of polypeptides in both prokaryotes and eukaryotes. The region of homology is highest in the approximately 200 amino acids which surround the nucleotide binding domains. The vast majority of these polypeptides transport molecules across biological membranes and have been designated the ATP binding cassette (ABC) transporters or traffic ATPases (Ames et al., 1992) . (Bairoch, 1992) . This consensus is manifested as the sequence LSGGQKQ-RIAIA in virtually all of the P-glycoproteins (Fig.  2) . In most members of this large group of polypeptides, however', the similarity is more extensive and in many, extends to predicted transmembrane domains. These transport proteins can be categorized into four major subgroups: multicomponent transport systems which include a small hydrophilic polypeptide with a nucleotide binding domain which either 1) shuttle substrates into bacteria, termed the periplasmic permease systems or 2) export substrates and toxins out of microorganisms, 3) polypeptides approximating one half of a Pglycoprotein with a hydrophobic and hydrophilic domain and 4) transport proteins with a structure similar to the P-glycoprotein comprised of two similar halves each containing transmembrane domains and a nucleotide binding domain (Fig. 8) . A variety of configurations are capable of transporting similar substrates in different organisms.
Bacterial permeases
The bacterial periplasmic permeases provide an energy dependent transport system for the uptake of nutrients in Gram negative bacteria (Ames et al., 1990; . These multicomponent systems provide a mechanism for specific sugars, metals, amino acids, peptides, or cofactors which have traversed the outer membrane into the periplasmic space to cross the inner cell membrane (Table 3 and Fig. 8 ). The perrneases are characteristically comprised of four individual polypeptides encoded in one or two operons. Each individual system includes a periplasmic substratebinding protein which is specific for the substrate. Although there is little primary amino acid homology amongst the substrate-binding proteins, a striking similarity in the tertiary structure has been deduced by x-ray crystallography (Adams and Oxender, 1989) . When bound to the substrate, the binding proteins undergo a conformational change which allows interaction with the membrane bound components of the system. The membrane bound components of the transport system are comprised of two hydrophobic polypeptides and a third member with a nucleotide binding domain. This latter polypeptide displays a high level of similarity 19 to the analogous member of each permease as welt as the entire cytoplasmic domain of the P-glycoprorein. The nucleic acid sequence encoding the region around the nucleotide binding domain even displays nucleic acid homology to the mammalian Pglycoproteins in some of the permeases such as potA of the spermidine and putrescine transport system, and braG of the branched chain amino acid transport system (data not shown). The two hydrophobic polypeptides are each comprised of five or six putative transmembrane domains with approximately 25--30% identical and an additional 25% conserved amino acid homology with each other. In a high affinity mycoplasma transport system, the hydrophobic proteins appear to be fused together as a single polypeptide which is consistent with the proposed function of the hydrophobic domains as pseudodimers . Some of the hydrophobic domains in different permeases di splay homology to each other and in some cases (upgE, araJ, oppB) even very faint homology to the Pglycoprotein (data not shown). Although the domain with homology to the cytoplasmic region of Pglycoprotein does not include a large number of hydrophobic residues, it appears to be membrane bound on the cytoplasmic side of the inner membrane (Ames, 1986) . In several of the permease systems this domain with the nucleotide binding fold is duplicated (mglA, rbsA, araG) and in the opp system there are two similar polypeptides with nucleotide binding domains, both of which are required for transport. ATP hydrolysis is tightly coupled to the transport of the substrates and presumably results in conformational changes which allow translocation of the substrate across the membrane. The entire permease complex, comprised of polypeptides containing twelve membrane spanning regions associated with two nonhydrophobic polypeptides which include nucleotide binding domains, suggests a functional unit quite similar to the predicted structure of the Pglycoprotein.
Multicomponent export systems
Hydrophilic polypeptides with homology to the cytoplasmic region of the P-glycoprotein act as members of multicomponent transport systems involved in the export of a variety of substrates from microorganisms (Table 3 and Fig. 8) . Streptomyces which produce doxorubicin and daunorubicin express two genes located in tandem which convey resistance to these antibiotics in heterologous hosts (Guilfoile and Hutchinson, 1991) . One of the polypeptides is hydrophilic and contains a nucleotide binding domain, drrA, and the other hydrophobic with six potential transmembrane domains, drrB. Another resistance operon in Streptomyces encodes oleC, a polypeptide comprised of a nucleotide binding domain, and a second hydrophobic polypeptide with six putative transmembrane domains. Together these polypeptides encode resistance to oleandomycin. Similarly, polypeptides containing two nucleotide binding domains linked in tandem have been identified in Streptomyces which produce macrolide antibiotics (Schoner et al., 1992) . These polypeptides act as specific resistance determinants in Streptomyces producing spiramycin, srmB, carbomycin, carA, and tylosin, tlrC, and appear to transport the antibiotics out of the organisms. Other potential members of the transport systems have not yet been identified. Bacterial operons responsible for the export of antibiotics have also been identified. Host resistance to the peptide, antibiotic microcin B17 is encoded in the mbcF gene in Enterobacteriaceae. The MbcF polypeptide includes a single nucleotide binding domain and interacts with a hydrophobic polypeptide to export microcin B17 from the cytoplasmic to the periplasmic space (Garrido et al., 1988) . The biosynthesis operon of the peptide, lantibiotic epidermin from Staphylococci similarly encodes a polypeptide with a nucleotide binding domain presumably responsible for export (Schnell et al., 1992) . Polypeptides consisting of duplicated nucleotide binding domains linked together encode an inducible mechanism of erythromycin resistance, msrA and virginiamycin resistance, vgA, in Staphylococci. MsrA has been shown to function by decreasing accumulation of the antibiotic (Ross et al., 1990) . The hydrophilic and hydrophobic domains of these multicomponent units presumably interact to transport the toxic antibiotics out of the organisms. Although, the structural organization of the efflux complexes have not yet been clarified, the similarity of the components to those found in bacterial permeases suggest that the two may be similar. Understanding the mechanism of substrate influx versus toxin efflux will certainly provide insight into the transport mechanisms of the Pglycoprotein. Multicomponent transport systems responsible for the transport of substrates which form the bacterial capsule and are responsible for microbial virulence have similarly been identified. The bexA gene encodes a hydrophilic polypeptide containing a nucleotide binding domain and bexB a polypeptide with six potential transmembrane domains in H. influenzae type b (Kroll et al., 1988) . Both are essential for polysaccharide export to the capsule and disruption of this complex results in loss of capsule formation. The polysaccharide capsule of N. meningitides requires the function of a similar operon, ctr. Similarly, kpsT and kpsM encode analogous proteins which are required for polysialic acid incorporation in the capsule of E. coli K1, the causative agent of neonatal septicemia and meningitis. These transport systems appear represent a generalized mechanism to translocate substrates across the cytoplasmic membrane for insertion in the capsule. Knowledge of these systems in pathogenic bacteria provide a new target for antibiotics by inhibition of substrate transport, analogous to the action of reversal agents in multidrug resistant cells. Several systems which may not transport substrates also include hydrophilic domains with homology to P-glycoprotein. The nodulation protein NodI from Rhizobium, which is required for the bacteria to form root nodules on leguminous host plants, includes a similar nucleotide binding domain (Rossen et al., 1984) . The ftsE gene is required by E. coli for cellular division. Within this operon is an open reading frame for a hydrophilic polypeptide which contains the consensus sequence for a nucleotide binding domain (Gill et al., 1986) . The ABC excinuclease of E. coli, an ATP dependent DNA repair enzyme, is made up of three subunits, including UvrA with a structure comprised of a duplication with nucleotide binding domains in each half (Husain et al., 1986) . Similarly, elongation factor-3 of S. cerevisiae, which appears to transduce energy for stimulation of aminoacyl tRNA binding to the ribosome, has a duplicated structure with a nucleotide binding domain in each half (Qin et al., 1990) . These diverse examples suggest that the functional unit used to bind and hydrolyze ATP in the transport systems can be utilized for ATP hydrolysis in a variety of cellular functions. This observation has further suggested that the hydrophobic domains of the transport complexes are responsible for substrate specificity and translocation.
Half P-glycoproteins
Polypeptides approximating one half of a P-glycoprotein, consisting of a series of transmembrane loops followed by a hydrophilic region containing a potential nucleotide binding domain, have been identified in both prokaryotes and eukaryotes (Table 3 and Fig. 8) . A series of prokaryotic transport proteins which export virulence toxins (HlyB, LtkB, CyaB, CIyI-B, CyaB), polysaccharides (NdvA, ChvA), antibiotics (CvaB, SpaB, LcnC, SyrD, NisT), protease activities (PrtD), heavy metals (Hmt), and the toxic compound aminotriazole (Atrl) have been identified. In addition, prokaryotic polypeptides which are involved in the formation of a polysaccharide layer during heterocyst differentiation (HetA), growth in temperatures greater than 32~ (MsbA), competence for genetic transformation (ComA) and association with a tRNA protein transferase (MdrA) have been shown to have a similar structure. The hydrophobicity plots of each of these polypeptides are very similar to either half of the P-glycoprotein. A comparison of the primary structure indicates an identical amino acid similarity to the P-glycoprotein ranging from 25--35% with an additional 20% conserved residues spanning the entire polypeptide. Similarity is highest in the hydrophilic domain with 40-45% identical amino acids. Significant nucleic acid similarity is even present between the mammalian P-glycoproteins and several of the prokaryotic sequences including hlyB, cyaB, msbA, lcnC, chvA in the range of 45% surrounding the nucleotide binding domain. Recently, two mammalian polypeptides have been implicated in the transport of short peptides from the cytosol into the endoplasmic reticulum where they are bound by the major histocompatibility class I molecules for antigen presentation (Bahram et al., 1991) . Each of these polypeptides appears to represent half of a P-glycoprotein with eight putative transmembrane domains followed by a cytoplasmic domain containing the consensus sequence for a nucleotide binding fold. Comparison of the amino acid sequences of the two peptide transporters indicates approximately 40% amino acid identity with an additional 20% conserved residues. Similarity is highest surrounding the nucleotide binding domain and decreases in the proximal regions. Comparison of the amino acid sequence of the human peptide transporters to human mdrl indicates approximately 30% identical and an additional 25% conserved amino acid residues. Both of the peptide transporters are slightly more similar to the carboxy half of the human P-glycoprotein. The genes encoding these peptide transporters are located within 10 kbp of each other in the major histocompatibility class II region. The two polypeptides appear to assemble and function as a heterodimer with both transporters required for the formation of stable class I molecules and antigen presentation (Kelly et al., 1992) . Again, the predicted functional structure appears similar to the proposed structure of the Pglycoprotein.
A second group of mammalian half P-glycoproteins are associated with peroxisomes. A partially deleted half P-glyeoprotein gene has been identified in some patients with adrenoleukodystrophy (ALD) (Mosser et al., 1993) . The principal abnormality in ALD is the accumulation of very-long-chain fatty acids due to impaired oxidation in peroxisomes. The candidate gene is suspected of translocating a component of the oxidative metabolic pathway into the organelle. This gene has highest similarity, 39% amino acid identity, with another 70 kD peroxisomal membrane protein, Humpmp, of unknown function (Kamijo et al., 1992) . It, too, however, is presumed to transport substrates into the peroxisome since the nucleotide binding domain is localized to the cytoplasmic side of the organelle. Both peroxisome transporters have approximately 20-25% amino acid identity with the peptide transporters as well as human mdrl, most of which surrounds the nucleotide binding domain.
The Drosophila white and brown gene products are structurally related to the P-glycoprotein. Each consists of a nucleotide binding fold followed by a series of transmembrane domains (O'Hare et al., 1984; Dreesen et al., 1988) . The products of these genes have been proposed to transport pigment precursors in the eye, possibly functioning as heterodimers (Dreesen et al., I988) . Similarly, an open reading frame identified during the sequencing of the yeast genome, Adpl, predicts a polypeptide with a similar structure which includes an epidermal growth factor motif. The transposition of the transmembrane and nucleotide binding domains relative to the organization found in the P-glycoprotein and half P-glycoprotein-like polypeptides would suggest that the functional units found in the bacterial permeases originally had significant latitude as building blocks in forming transport proteins (Fig. 8) .
P-glycoprotein-Iike transporters
Analysis of the gene responsible for cystic fibrosis indicates that it has amino acid homology and a similar structure to the P-glycoprotein (Riordan et al., 1989) . The amino acid sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) predicts a polypeptide 1480 amino acids long with two repeat motifs, each which consists of six membrane spanning domains and a hydrophilic region containing the consensus sequences for a nucleotide binding fold. The two halves of the polypeptide display only 21% amino acid identity with each other and 15% amino acid identity with the mammalian P-glycoproteins. The only homology surrounds the nucleotide binding domain. A large, highly charged cytoplasmic domain of 241 amino acids, termed the R group, contains a cluster of consensus sequences for protein kinase A and protein kinase C phosphorylation sites and links the two halves of the molecule at the analogous position of the "linker" region in the P-glycoprotein.
A number of cell lines displaying a cross resistant phenotype similar to multidrug resistant cell lines but which do not overexpress the P-glycoprotein have been isolated by stepwise selection in doxorubicin (Mirski et al., 1987; McGrath and Center, 1988; Baas et al., 1990; Slapak et al., 1990) . Recently, a multidrug resistance-associated protein, MRP, has been identified in one such cell line by differential hybridization (Cole et al., 1992) . Molecular analyses indicate that the gene encoding MRP is amplified and overexpressed in the resistant cell line. Although the line displays resistance to multiple agents, cyclosporin A does not reverse the resistance and major differences in net drug accumulation do not appear to be part of the resistant phenotype. Analysis of the predicted amino acid sequence of MRP indicates homology to the P-glycoprotein with two similar halves each containing a nucleotide binding domain. The hydrophobicity analysis, however, was used to assign eight transmembrane domains in the proximal half of the polypeptide and four in the distal half. Other predictions are possible including up to 12 transmembrane domains in the proximal and six in the distal halves. This cluster of potential transmembrane domains at the amino terminus is distinct from all of the other P-glycoprotein homologs. Although the proximal and distal halves are similar, the homology is primarily located around the nucleotide binding domain and the two halves are not as similar to each other as most P-glycoprotein homologs (Fig. 3) , MRP displays highest similarity to LtpgpA and CFTR with approximately 30 and 24% amino acid identity, respectively, with only about 15% amino acid identity to any of the Pglycoproteins (Fig. 5 ). These observations have suggested that MRP, LtpgpA and CFTR are more closely related to each other than the other P-glycoprotein homologs and represent a separate grouping which originated from different precursors or 25 diverged before the separation of plants and animals (Cole et al., 1992) . Of note, however, the nucleic acid sequence surrounding the nucleotide binding domain is more similar to the P-glycoproteins than LtpgpA or CFTR (data not shown).
The predicted structure of the P-glycoprotein is similar to a variety of channels and transport proteins but lacks substantial similarity to their amino acid sequences. A consensus structure consisting of 12 c(-helical, transmembrane spanning domains has been proposed for a wide range of transport systems which require of energy coupling (Malone, 1990) . Primary sequence comparisons have identified a putative "major facilitator superfamily" comprised of drug resistance proteins, sugar facilitators, Krebs cycle intermediates which symport H § phosphate ester-phosphate antiporters and oligosaccharide-H + symporters with this structure (Marger and Saier, 1993) . In addition, this generalized structure is found in adenylyl cyclase which is comprised of two similar halves each containing six transmembrane domains and a large hydrophilic region with a cyclic nucleotide binding domain (Kupinski et al., 1989) . Voltage-gated sodium (Noda et al., 1986 ) and calcium channels (Tanabe et al., 1987) are comprised of four similar groups each including six transmembrane spanning domains. These hydrophobic regions are interspersed with cytoplasmic domains predicting a structure not dissimilar to a pair of linked P-glycoproteins. The P-glycoprotein, however, does not display significant homology at the amino acid level to these transport proteins and channels. Whether the lack of amino acid homology with structural homology represents divergence from the ancestral origins of the transport proteins or convergence to motifs which perform similar functional activities is unknown.
Evolutionary origins of the P-glycoprotein
The P-glycoprotein is the member of a large superfamily of transport proteins which move a wide range of substrates across plasma membranes. The general structure of 12 membrane spanning domains and two hydrophilic moieties which include nucleotide binding domains appears similar across large evolutionary distances. However, the composition of the functional units comprising the structure varies and a range of combinations can direct transport in and out of the cell as well as across different organelles. Cytotoxic compounds are exported not only by P-glycoproteins, but also by multicomponent transport systems and half Pglycoproteins in a variety organisms.
Although the functional domains of the P-glycoprotein are observed in both prokaryotes and eukaryotes, the precise evolutionary origins have been a matter of speculation. The observation that the two halves of the P-glycoprotein displayed a high level of amino acid homology originally suggested that the polypeptide represented gene duplication of a primordial gene. Identification of the intron/exon boundaries of the human mdrl (Chen et al., 1990) , mdr3 (Lincke et al., 1991) and mouse mdrl ) P-glycoproteins have provided more information on the possible evolutionary mechanisms involved. Each of the mammalian homologs contains 28 exons with introns placed at homologous sites along the gene. The most notable feature is that the majority of the boundaries in the proximal and distal halves of the gene do not occur at the corresponding locations in the two halves. Only two intron boundaries are located at identical nucleotides in the two halves and occur within the nucleotide binding domain. Another intron boundary in a hydrophobic region occurs at the same amino acid. The lack of similarity between the halves suggested that the Pglycoprotein may have originated from two genes with common ancestors evolving separately prior to fusion (Chen et al., 1990) . However, since both moieties have a similar number of exons, over 50% nucleic acid identity in the coding regions and the exons appear to encode functional domains, the theory for gene duplication has similarly been advanced . Further insight has been provided with determination of the intrordexon boundaries of the A. thaliana homolog (Dudler and Hertig, 1992) . Nine introns have been identified, eight in the proximal half and one in the distal half. None of the introns in the proximal half match the position of the intron in the distal half.
Four of the introns correspond to similar positions in the mammalian gene including two in the proximal half aligning with the introns which are identical in the nucleotide binding domain. In addition, however, three introns in one half of the A. thaliana homolog correspond to introns in the opposite half of the mammalian gene. Preliminary observations in the C. eIegans (Lincke et al., 1992) and Drosophila homologs (J. Croop, unpublished data) suggest a similar conservation of introns in one half of the homolog with introns in the contralateral half of the mammalian gene. These latter observations suggest that a duplicated primordial gene could have differentially lost introns to account for the variability between the proximal and distal halves of the mammalian P-glycoprotein. This would also explain the similarity found in intron location across different halves in the evolutionarily divergent homologs (Dudler and Hertig, 1992) . Such a scenario, however, might be expected to lead to exons with larger than average size in the mammalian gene, which is not the case (Chen et al., 1990) .
Examination of the similarity among the currently described P-glycoproteins reveals several distinct groupings which presumably have evolutionary significance. The mammalian P-glycoproteins can be identified as a single group with over 65% identity amongst all of the homologs as indicated in Figs. 5 and 7. Within each species, the mammalian P-glycoproteins display very high levels of similarity in the range of 72--85%. A similar level of homology is present between the strain specific lemdrl and ldmdrl, but is not found among the homologs in other organisms. The two E. histolytica approach this level of homology with 68% identity, but the homologs in Drosophila and C. elegans are as divergent from each other as they are from the other P-glycoproteins (Fig. 5) . Interestingly, most of the homologs, except as noted above, display a slightly higher homology to a mammalian P-glycoprotein than any other homolog (data not shown). The recently described clustering of homologies among Itpgpl, Mrp and CFTR can similarly be seen in Figs. 5 and 7 (Cole et al., 1992) . However, note that the amino acid identities among these three homologs are only 20--30% compared to approximately 15% identity with each of the other P-glycoprotein homologs. The majority of the remaining homologs display over 30% amino acid identity to one another. The exceptions are pfindrt, Ste6 and Mdl which appear to represent a separate grouping with only 20-30% amino acid identity with the other homologs. These four groups are similarly distinguished in the pairings found in Fig. 7 .
Direct comparisons of the P-glycoprotein homologs to human mdrl support these groupings. Figure 4A clearly indicates the high level of homology to the mammalian P-glycoproteins, a lesser but similar level of homology to each of the re- (Fig. 4B) . In addition, a BLAST search of the genetic databases (Altshul et al., 1990) to identify proteins with homology to human mdrl indicates a similar clustering of the homologs. Table 3 However, a number of half P-glycoproteins and multicomponent transport genes are identified. Finally, BLAST searches with the nucleic acid sequences from the carboxy half of the mammalian P-glycoproteins consistently match many more of the homologs as well as other polypeptides with evolutionary homology than searches with the amino end.
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Characterization of the differences in homology between the proximal and distal halves of the Pglycoprotein homologs is also consistent with the assignment of these groupings. The mammalian Pglycoproteins display the highest levels of homology between the two halves with approximately 40% identical amino acid residues. The majority of the remaining homologs are 30-40% identical, while Itpgpl, Mrp and CFTR are 21--23% identical. The two halves of pfmdrl, Ste6 and Mdl range from 24 to 29% identity. Differential levels of similarity between the two halves suggest that the structural or functional requirements have evolved over time. Unfortunately, the normal physiological roles for most P-glycoproteins are unknown so it is difficult determine the significance of these differences. Since, in general, the carboxy and amino halves are more similar to the respective halves among P-glycoprotein homologs (data not shown), either similarity remains to the original ancestral moieties which fused to form the P-glycoprotein or divergence between the two halves of a duplicated gene occurred prior to further radiation. Whether or not these and similar comparisons will further delineate distinct groupings or a graded continuum of differences between the homologs awaits the identification of additional P-glycoproteins.
